The extra-domain a of fibronectin is a vascular marker of solid tumors and Metastases

被引:165
作者
Rybak, Jascha-N.
Roesli, Christoph
Kaspar, Manuela
Villa, Alessandra
Neri, Dario
机构
[1] Swiss Fed Inst Technol, Inst Pharmaceut Sci, Dept Chem & Appl Biosci, CH-8093 Zurich, Switzerland
[2] Swiss Fed Inst Technol, Philochem AG, Zurich, Switzerland
关键词
D O I
10.1158/0008-5472.CAN-07-1436
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
One of the most promising new avenues for the development of more selective and efficacious cancer therapies relies on the antibody- mediated targeted delivery of bioactive agents (e.g., cytokines) to the tumor environment. The identification of quantitative differences in the expression of accessible vascular proteins in metastatic lesions and host organs facilitate the development of antibody-based strategies, which should be highly efficient and selective, considering the fact that an over-exuberant neovasculature is a characteristic feature of aggressive cancers, and that tumor blood vessels are readily accessible for i.v. administered therapeutic agents. Metastasis is the main cause of death in cancer. The availability of metastasis- specific antigens accessible from the bloodstream will allow a selective delivery of therapeutic agents to metastatic lesions using antibodies as vehicles. Using a combination of vascular biotinylation of 129Sv mice bearing F9 liver metastases and mass spectrometry, we have identified 435 accessible proteins in metastasis and host organ specimens, of which 117 were exclusively detected in metastases. In particular, we found that the alternatively spliced extra-domain A (EDA) of fibronectin is strongly expressed in the neovasculature of liver metastases, while being undetectable in most normal organs. A human antibody to EDA was used to show EDA expression in the neovasculature of metastases and primary tumors of human cancer patients and to target mouse liver metastases and subcutaneous tumors in vivo. Human antibody fragments specific to the EDA domain of fibronectin promise to serve as general vehicles for the efficient and selective delivery of imaging agents or therapeutic molecules to metastatic sites.
引用
收藏
页码:10948 / 10957
页数:10
相关论文
共 50 条
[1]  
Adams GP, 2001, CANCER RES, V61, P4750
[2]   Monoclonal antibody therapy of cancer [J].
Adams, GP ;
Weiner, LM .
NATURE BIOTECHNOLOGY, 2005, 23 (09) :1147-1157
[3]   Lack of specificity of endoglin expression for tumor blood vessels [J].
Balza, E ;
Castellani, P ;
Zulstra, A ;
Neri, D ;
Zardi, L ;
Siri, A .
INTERNATIONAL JOURNAL OF CANCER, 2001, 94 (04) :579-585
[4]  
Bergijk EC, 1996, J PATHOL, V178, P462
[5]   Radioimmunotherapy of solid tumors by targeting extra domain B fibronectin: Identification of the best-suited radioimmunoconjugate [J].
Berndorff, D ;
Borkowski, S ;
Sieger, S ;
Rother, A ;
Friebe, M ;
Viti, F ;
Hilger, CS ;
Cyr, JE ;
Dinkelborg, LM .
CLINICAL CANCER RESEARCH, 2005, 11 (19) :7053S-7063S
[6]  
Berndorff D, 2006, J NUCL MED, V47, P1707
[7]   Infrared photodetection for the in vivo localisation of phage-derived antibodies directed against angiogenic markers [J].
Birchler, M ;
Neri, G ;
Tarli, L ;
Halin, C ;
Viti, F ;
Neri, D .
JOURNAL OF IMMUNOLOGICAL METHODS, 1999, 231 (1-2) :239-248
[8]   Preparation of phage antibodies to the ED-A domain of human fibronectin [J].
Borsi, L ;
Castellani, P ;
Allemanni, G ;
Neri, D ;
Zardi, L .
EXPERIMENTAL CELL RESEARCH, 1998, 240 (02) :244-251
[9]   Selective targeting of tumoral vasculature: Comparison of different formats of an antibody (L19) to the ED-B domain of fibronectin [J].
Borsi, L ;
Balza, E ;
Bestagno, M ;
Castellani, P ;
Carnemolla, B ;
Biro, A ;
Leprini, A ;
Sepulveda, J ;
Burrone, O ;
Neri, D ;
Zardi, L .
INTERNATIONAL JOURNAL OF CANCER, 2002, 102 (01) :75-85
[10]   MONOCLONAL-ANTIBODIES IN THE ANALYSIS OF FIBRONECTIN ISOFORMS GENERATED BY ALTERNATIVE SPLICING OF MESSENGER-RNA PRECURSORS IN NORMAL AND TRANSFORMED HUMAN-CELLS [J].
BORSI, L ;
CARNEMOLLA, B ;
CASTELLANI, P ;
ROSELLINI, C ;
VECCHIO, D ;
ALLEMANNI, G ;
CHANG, SE ;
TAYLORPAPADIMITRIOU, J ;
PANDE, H ;
ZARDI, L .
JOURNAL OF CELL BIOLOGY, 1987, 104 (03) :595-600